Comparison of [11C]Choline ([11C]CHO) and S(+)-β-Methyl-[11C]Choline ([11C]SMC) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model

Molecular Imaging and Biology

Volumn 17, Issue 2, 2015, Pages 248-256

  Schwarzenböck, Sarah Marie ^a,b   Gertz, Jana ^b   Souvatzoglou, Michael ^a   Kurth, Jens ^b   Sachs, David ^a   Nawroth, Roman ^a   Treiber, Uwe ^a   Schuster, Tibor ^c   Senekowitsch Schmidtke, Reingard ^a   Schwaiger, Markus ^a   Ziegler, Sibylle Ilse ^a   Henriksen, Gjermund ^c   Wester, Hans Jürgen ^c   Krause, Bernd Joachim ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Choline; Prostate cancer; Small animal PET CT; Xenograft

Indexed keywords

ANDROGEN RECEPTOR; CHOLINE C 11; RADIOPHARMACEUTICAL AGENT; SULFUR BETA METHYL CHOLINE C 11; TRACER; UNCLASSIFIED DRUG; BETA-METHYLCHOLINE; CARBON; CHOLINE; MOLECULAR PROBE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; IMAGE ANALYSIS; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; THIGH; TISSUE SLICE; TUMOR CELL LINE; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG SCREENING; HUMAN; MOLECULAR PROBE; MUSCLE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING; TIME;

ANIMALIA; MUS;

ANIMALS; CARBON RADIOISOTOPES; CELL LINE, TUMOR; CHOLINE; HUMANS; MALE; MICE, NUDE; MOLECULAR PROBES; MUSCLES; PROSTATIC NEOPLASMS; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84924548772     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0782-8     Document Type: Article

References (26)

1. 18F] fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol 168:273–280
2. Zheng QH, Gardner TA, Raikwar S et al (2004) [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem 12:2887–2893
3. Krause BJ, Souvatzoglou M, Herrmann K et al (2010) [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model. Eur J Nucl Med Mol Imaging 37:1861–1868
4. Schwarzenbock S, Sachs D, Souvatzoglou M et al (2013) [11C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model. Nuklearmedizin 52:141–147
5. Ramirez de Molina A, Penalva V, Lucas L, Lacal JC (2002) Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K. Oncogene 21:937–946
6. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R et al (2002) Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 296:580–583
7. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61:3599–3603
8. Hara T, Bansal A, DeGrado TR (2006) Choline transporter as a novel target for molecular imaging of cancer. Mol Imaging 5:498–509
9. Katz-Brull R, Degani H (1996) Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 16:1375–1380
10. Ratnam S, Kent C (1995) Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys 323:313–322
11. Holzapfel K, Muller SA, Seidl C et al (2008) Effects of irradiation on the [Methyl-3H] choline uptake in the human prostate cancer cell lines LNCaP and PC3. Strahlenther Onkol 184:319–324
12. Kaighn ME, Narayan KS, Ohnuki Y et al (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol 17:16–23
13. Muller SA, Holzapfel K, Seidl C et al (2009) Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. Eur J Nucl Med Mol Imaging 36:1434–1442
14. Ferguson SS, Diksic M, Collier B (1991) Stereospecificity of high- and low-affinity transport of choline analogues into rat cortical synaptosomes. J Neurochem 57:915–921
15. Hara T, Yuasa M (1999) Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 50:531–533
16. Henriksen G, Herz M, Hauser A et al (2004) Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F] fluorocholine ([18F] dOC). Nucl Med Biol 31:851–858
17. Bao Q, Newport D, Chen M et al (2009) Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med: Off Publ Soc Nucl Med 50:401–408
18. Elsasser-Beile U, Reischl G, Wiehr S et al (2009) PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. J Nucl Med 50:606–611
19. Afshar-Oromieh A, Haberkorn U, Eder M et al (2012) [68Ga] Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH. Eur J Nucl Med Mol Imaging 39:1085–1086
20. Alt K, Wiehr S, Ehrlichmann W et al (2010) High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA. Prostate 70:1413–1421
21. Dijkgraaf I, Franssen GM, McBride WJ et al (2012) PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. J Nucl Med 53:947–952
22. Zhang X, Cai W, Cao F et al (2006) 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 47:492–501
23. Biddlecombe GB, Rogers BE, de Visser M et al (2007) Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1, Tyr4)-bombesin (1–14). Bioconjug Chem 18:724–730
24. Fournier P, Dumulon-Perreault V, Ait-Mohand S et al (2012) Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64) Cu/and (68) Ga/NOTA-PEG-[D-Tyr (6), betaAla (11), Thi (13), Nle (14)] BBN (6–14). Bioconjug Chem 23:1687–1693
25. Liu Z, Li ZB, Cao Q et al (2009) Small-animal PET of tumors with (64) Cu-labeled RGD-bombesin heterodimer. J Nucl Med 50:1168–1177
26. Yang YS, Zhang X, Xiong Z, Chen X (2006) Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nucl Med Biol 33:371–380